Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
Saved in:
| Title: | Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms. |
|---|---|
| Authors: | Pieri L; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Paoli C; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Arena U; Internal Medicine and Hepatology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy., Marra F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Mori F; Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy., Zucchini M; Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy., Colagrande S; Department of Experimental and Clinical Biomedical Sciences, University of Florence - Azienda Ospedaliera-Universitaria Careggi, Florence, Italy., Castellani A; Department of Experimental and Clinical Biomedical Sciences, University of Florence - Azienda Ospedaliera-Universitaria Careggi, Florence, Italy., Masciulli A; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy., Rosti V; IRCCS Policlinico San Matteo Foundation, Center for the Study of Myelofibrosis, Biotechnology Research Area, Pavia, Italy., De Stefano V; Institute of Hematology, Catholic University, Rome, Italy., Betti S; Institute of Hematology, Catholic University, Rome, Italy., Finazzi G; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy., Ferrari ML; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy., Rumi E; Department of Hematology Oncology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Ruggeri M; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Nichele I; Department of Hematology, San Bortolo Hospital, Vicenza, Italy., Guglielmelli P; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Fjerza R; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Mannarelli C; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Fanelli T; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; University of Siena, Siena, Italy., Merli L; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Corbizi Fattori G; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; University of Siena, Siena, Italy., Massa M; IRCCS Policlinico San Matteo Foundation, Biotechnology Research Area, Pavia, Italy., Cimino G; Department of Cellular Biotechnology and Hematology, University 'La Sapienza', Rome, Italy., Rambaldi A; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy., Barosi G; IRCCS Policlinico San Matteo Foundation, Center for the Study of Myelofibrosis, Biotechnology Research Area, Pavia, Italy., Cazzola M; Department of Hematology Oncology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Barbui T; Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy., Vannucchi AM; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. |
| Source: | American journal of hematology [Am J Hematol] 2017 Feb; Vol. 92 (2), pp. 187-195. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27880982 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pieri+L%22">Pieri L</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Paoli+C%22">Paoli C</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Arena+U%22">Arena U</searchLink>; Internal Medicine and Hepatology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Marra+F%22">Marra F</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Mori+F%22">Mori F</searchLink>; Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Zucchini+M%22">Zucchini M</searchLink>; Department of Cardiology, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Colagrande+S%22">Colagrande S</searchLink>; Department of Experimental and Clinical Biomedical Sciences, University of Florence - Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Castellani+A%22">Castellani A</searchLink>; Department of Experimental and Clinical Biomedical Sciences, University of Florence - Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Masciulli+A%22">Masciulli A</searchLink>; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Rosti+V%22">Rosti V</searchLink>; IRCCS Policlinico San Matteo Foundation, Center for the Study of Myelofibrosis, Biotechnology Research Area, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22De+Stefano+V%22">De Stefano V</searchLink>; Institute of Hematology, Catholic University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Betti+S%22">Betti S</searchLink>; Institute of Hematology, Catholic University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Finazzi+G%22">Finazzi G</searchLink>; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Ferrari+ML%22">Ferrari ML</searchLink>; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Rumi+E%22">Rumi E</searchLink>; Department of Hematology Oncology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Ruggeri+M%22">Ruggeri M</searchLink>; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.<br /><searchLink fieldCode="AU" term="%22Nichele+I%22">Nichele I</searchLink>; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.<br /><searchLink fieldCode="AU" term="%22Guglielmelli+P%22">Guglielmelli P</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Fjerza+R%22">Fjerza R</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Mannarelli+C%22">Mannarelli C</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Fanelli+T%22">Fanelli T</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; University of Siena, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Merli+L%22">Merli L</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Corbizi+Fattori+G%22">Corbizi Fattori G</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; University of Siena, Siena, Italy.<br /><searchLink fieldCode="AU" term="%22Massa+M%22">Massa M</searchLink>; IRCCS Policlinico San Matteo Foundation, Biotechnology Research Area, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Cimino+G%22">Cimino G</searchLink>; Department of Cellular Biotechnology and Hematology, University 'La Sapienza', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Rambaldi+A%22">Rambaldi A</searchLink>; Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Barosi+G%22">Barosi G</searchLink>; IRCCS Policlinico San Matteo Foundation, Center for the Study of Myelofibrosis, Biotechnology Research Area, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Cazzola+M%22">Cazzola M</searchLink>; Department of Hematology Oncology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Barbui+T%22">Barbui T</searchLink>; Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Vannucchi+AM%22">Vannucchi AM</searchLink>; CRIMM-Centro Ricerca e Innovazione per le Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.; DenoThe Excellence Center, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2017 Feb; Vol. 92 (2), pp. 187-195. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27880982 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ajh.24614 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 187 Titles: – TitleFull: Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pieri L – PersonEntity: Name: NameFull: Paoli C – PersonEntity: Name: NameFull: Arena U – PersonEntity: Name: NameFull: Marra F – PersonEntity: Name: NameFull: Mori F – PersonEntity: Name: NameFull: Zucchini M – PersonEntity: Name: NameFull: Colagrande S – PersonEntity: Name: NameFull: Castellani A – PersonEntity: Name: NameFull: Masciulli A – PersonEntity: Name: NameFull: Rosti V – PersonEntity: Name: NameFull: De Stefano V – PersonEntity: Name: NameFull: Betti S – PersonEntity: Name: NameFull: Finazzi G – PersonEntity: Name: NameFull: Ferrari ML – PersonEntity: Name: NameFull: Rumi E – PersonEntity: Name: NameFull: Ruggeri M – PersonEntity: Name: NameFull: Nichele I – PersonEntity: Name: NameFull: Guglielmelli P – PersonEntity: Name: NameFull: Fjerza R – PersonEntity: Name: NameFull: Mannarelli C – PersonEntity: Name: NameFull: Fanelli T – PersonEntity: Name: NameFull: Merli L – PersonEntity: Name: NameFull: Corbizi Fattori G – PersonEntity: Name: NameFull: Massa M – PersonEntity: Name: NameFull: Cimino G – PersonEntity: Name: NameFull: Rambaldi A – PersonEntity: Name: NameFull: Barosi G – PersonEntity: Name: NameFull: Cazzola M – PersonEntity: Name: NameFull: Barbui T – PersonEntity: Name: NameFull: Vannucchi AM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2017 Feb Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1096-8652 Numbering: – Type: volume Value: 92 – Type: issue Value: 2 Titles: – TitleFull: American journal of hematology Type: main |
| ResultId | 1 |